Evaluation of the safety of vaccinating mares against equine viral arteritis during mid or late gestation or during the immediate postpartum period

Charles C. Broaddus Department of Clinical Sciences, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK 74048.

Search for other papers by Charles C. Broaddus in
Current site
Google Scholar
PubMed
Close
 DVM, DACT
,
Udeni B. R. Balasuriya Gluck Equine Research Center, Department of Veterinary Science, College of Agriculture, University of Kentucky, Lexington, KY 40546.

Search for other papers by Udeni B. R. Balasuriya in
Current site
Google Scholar
PubMed
Close
 BVSc, PhD
,
Jena L. R. White Gluck Equine Research Center, Department of Veterinary Science, College of Agriculture, University of Kentucky, Lexington, KY 40546.

Search for other papers by Jena L. R. White in
Current site
Google Scholar
PubMed
Close
,
Peter J. Timoney Gluck Equine Research Center, Department of Veterinary Science, College of Agriculture, University of Kentucky, Lexington, KY 40546.

Search for other papers by Peter J. Timoney in
Current site
Google Scholar
PubMed
Close
 MVB, PhD
,
Rebecca A. Funk Department of Clinical Sciences, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK 74048.

Search for other papers by Rebecca A. Funk in
Current site
Google Scholar
PubMed
Close
 DVM, MS
, and
G. Reed Holyoak Department of Clinical Sciences, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK 74048.

Search for other papers by G. Reed Holyoak in
Current site
Google Scholar
PubMed
Close
 DVM, PhD, DACT

Abstract

Objective—To determine whether it is safe to vaccinate pregnant or postpartum mares with a commercial modified-live virus vaccine against equine viral arteritis (EVA).

Design—Randomized controlled study.

Animals—73 mares and their foals.

Procedures—Mares were vaccinated during mid gestation, during late gestation, or 2 or 3 days after parturition with a commercial modified-live virus vaccine or were not vaccinated. Foaling outcomes were recorded, and serum, blood, milk, and nasopharyngeal samples were obtained.

Results—All mares vaccinated during mid gestation foaled without any problems; 21 of 22 mares in this group had antibody titers against EAV at the time of foaling. Of the 19 mares vaccinated during late gestation, 3 aborted; antibody titers against EAV were detected in 13 of 15 mares from which serum was obtained at the time of foaling. All postparturient vaccinates were seronegative at foaling; all of them seroconverted after vaccination. No adverse effects were detected in any of their foals.

Conclusions and Clinical Relevance—When faced with a substantial risk of natural exposure to EAV, it would appear to be safe to vaccinate healthy pregnant mares up to 3 months before foaling and during the immediate postpartum period. Vaccinating mares during the last 2 months of gestation was associated with a risk of abortion; this risk must be weighed against the much greater risk of widespread abortions in unprotected populations of pregnant mares naturally infected with EAV.

Abstract

Objective—To determine whether it is safe to vaccinate pregnant or postpartum mares with a commercial modified-live virus vaccine against equine viral arteritis (EVA).

Design—Randomized controlled study.

Animals—73 mares and their foals.

Procedures—Mares were vaccinated during mid gestation, during late gestation, or 2 or 3 days after parturition with a commercial modified-live virus vaccine or were not vaccinated. Foaling outcomes were recorded, and serum, blood, milk, and nasopharyngeal samples were obtained.

Results—All mares vaccinated during mid gestation foaled without any problems; 21 of 22 mares in this group had antibody titers against EAV at the time of foaling. Of the 19 mares vaccinated during late gestation, 3 aborted; antibody titers against EAV were detected in 13 of 15 mares from which serum was obtained at the time of foaling. All postparturient vaccinates were seronegative at foaling; all of them seroconverted after vaccination. No adverse effects were detected in any of their foals.

Conclusions and Clinical Relevance—When faced with a substantial risk of natural exposure to EAV, it would appear to be safe to vaccinate healthy pregnant mares up to 3 months before foaling and during the immediate postpartum period. Vaccinating mares during the last 2 months of gestation was associated with a risk of abortion; this risk must be weighed against the much greater risk of widespread abortions in unprotected populations of pregnant mares naturally infected with EAV.

Contributor Notes

Ms. White's present address is Department of Rehabilitation Sciences, College of Health Sciences, University of Kentucky, Lexington, KY 40536.

Dr. Funk's present address is Department of Clinical Sciences, Virginia-Maryland Regional College of Veterinary Medicine, Virginia Tech, Blacksburg, VA 24061.

Dr. Broaddus' present address is Virginia Department of Agriculture and Consumer Services, 102 Governor St, Richmond, VA 23219.

Supported by Fort Dodge Animal Health.

The authors thank Dr. Mark Payton for assistance with the statistical analysis.

Address correspondence to Dr. Broaddus (charles.broaddus@vdacs.virginia.gov).
  • 1.

    Timoney PJ, McCollum WH. Equine viral arteritis. Vet Clin North Am Equine Pract 1993; 9:295309.

  • 2.

    McCollum WH, Timoney PJ, Lee J Jr, et al. Features of an outbreak of equine viral arteritis on a breeding farm associated with abortion and fatal interstitial pneumonia in neonatal foals, in Proceedings. 8th Int Conf Equine Infect Dis 1998;559–560.

    • Search Google Scholar
    • Export Citation
  • 3.

    Cavanagh D. Nidovirales: a new order comprising Coronaviridae and Arteriviridae. Arch Virol 1997; 142:629633.

  • 4.

    Snijder EJ, Meulenberg JJ. The molecular biology of arteriviruses. J Gen Virol 1998; 79:961979.

  • 5.

    Balasuriya UBR, MacLachlan NJ. Equine viral arteritis. In: Sellon DC, Long M, eds. Equine infectious diseases. Philadelphia: Saunders, 2006;153164.

    • Search Google Scholar
    • Export Citation
  • 6.

    Holyoak GR, Balasuriya UB, Broaddus CC, et al. Equine viral arteritis: current status and prevention. Theriogenology 2008; 70:403414.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7.

    National Animal Health Monitoring System. Equine viral arteritis (EVA) and the US horse industry. Fort Collins, Colo: USDA APHIS, 2000.

  • 8.

    Hullinger PJ, Gardner IA, Hietala SK, et al. Seroprevalence of antibodies against equine arteritis virus in horses residing in the United States and imported horses. J Am Vet Med Assoc 2001; 219:946949.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9.

    Timoney PJ, McCollum WH. Equine viral arteritis: epidemiology and control. J Equine Vet Sci 1988; 8:5459.

  • 10.

    McCollum WH, Bryans JT. Serological identification of infection by equine arteritis virus in horses of several countries, in Proceedings. 3rd Int Conf Equine Infect Dis 1973;256263.

    • Search Google Scholar
    • Export Citation
  • 11.

    McCue PM, Hietala SK, Spensely MS, et al. Prevalence of equine viral arteritis in California horses. Calif Vet 1991; 45:2426.

  • 12.

    McKenzie J. Survey of stallions for equine viral arteritis. Surveillance 1996; 16:1718.

  • 13.

    Moraillon A, Moraillon R. Results of an epidemiological investigation on viral arteritis in France and some other European and African countries. Ann Rech Vet 1978; 9:4354.

    • Search Google Scholar
    • Export Citation
  • 14.

    Doll ER, Knappenberger RE, Bryans JT. An outbreak of abortion caused by the equine arteritis virus. Cornell Vet 1957; 47:6975.

  • 15.

    Timoney PJ, McCollum WH, Murphy TW, et al. The carrier state in equine arteritis virus infection in the stallion with specific emphasis on the venereal mode of virus transmission. J Reprod Fertil Suppl1987;(35):95102.

    • Search Google Scholar
    • Export Citation
  • 16.

    Cole JR, Hall RF, Gosser HS, et al. Transmissibility and abortogenic effect of equine viral arteritis in mares. J Am Vet Med Assoc 1986; 189:769771.

    • Search Google Scholar
    • Export Citation
  • 17.

    McCollum WH, Prickett ME, Bryans JT. Temporal distribution of equine arteritis virus in respiratory mucosa, tissues and body fluids of horses infected by inhalation. Res Vet Sci 1971; 12:459464.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18.

    Timoney PJ, McCollum WH, Roberts AW, et al. Demonstration of the carrier state in naturally acquired equine arteritis virus infection in the stallion. Res Vet Sci 1986; 41:279280.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19.

    Little TV, Holyoak GR, McCollum WH, et al. Output of equine arteritis virus from persistently infected stallions is testosterone dependent, in Proceedings. 6th Int Conf Equine Infect Dis 1992;225229.

    • Search Google Scholar
    • Export Citation
  • 20.

    Holyoak GR, Little TV, McCollum WH, et al. Relationship between onset of puberty and establishment of persistent infection with equine arteritis virus in the experimentally infected colt. J Comp Pathol 1993; 109:2946.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 21.

    Henson JB, Crawford TB. The pathogenesis of virus-induced arterial disease—Aleutian disease and equine viral arteritis. Adv Cardiol 1974; 13:183191.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 22.

    Neu SM, Timoney PJ, McCollum WH. Persistent infection of the reproductive tract in stallions experimentally infected with equine arteritis virus, in Proceedings. 5th Int Conf Equine Infect Dis 1987;149154.

    • Search Google Scholar
    • Export Citation
  • 23.

    Guthrie AJ, Howell PG, Hedges JF, et al. Lateral transmission of equine arteritis virus among Lipizzaner stallions in South Africa. Equine Vet J 2003; 35:596600.

    • Search Google Scholar
    • Export Citation
  • 24.

    Doll ER, Crowe ME, Doll ER, et al. Isolation of a filterable agent causing arteritis of horses and abortion by mares; its differentiation from the equine abortion (influenza) virus. Cornell Vet 1957; 47:341.

    • Search Google Scholar
    • Export Citation
  • 25.

    Bryans JT, Doll ER, Jones TC. The lesions of equine viral arteritis. Cornell Vet 1957; 47:5268.

  • 26.

    Holyoak GR, Giles RC, McCollum WH, et al. Pathological changes associated with equine arteritis virus infection of the reproductive tract in prepubertal and peripubertal colts. J Comp Pathol 1993; 109:281293.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 27.

    Coignoul FL, Cheville NF. Pathology of maternal genital tract, placenta, and fetus in equine viral arteritis. Vet Pathol 1984; 21:333340.

  • 28.

    Estes PC, Cheville NF. The ultrastructure of vascular lesions in equine viral arteritis. Am J Pathol 1970; 58:235253.

  • 29.

    Doll ER, Bryans JT, Wilson JC, et al. Immunization against equine viral arteritis using modified live virus propagated in cell cultures of rabbit kidney. Cornell Vet 1968; 58:497524.

    • Search Google Scholar
    • Export Citation
  • 30.

    McCollum WH. Vaccination for equine viral arteritis, in Proceedings. 2nd Int Conf Equine Infect Dis 1970;143151.

  • 31.

    Timoney PJ, Fallon L, Shuck K, et al. The outcome of vaccinating five pregnant mares with a commercial equine viral arteritis vaccine. Equine Vet Educ 2007; 19:606611.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 32.

    Timoney PJ, Creekmore L, Meade B, et al. 2006 Multi-state occurrence of EVA, in Proceedings. 110th Annu Meet US Anim Health Assoc 2006;354–362.

    • Search Google Scholar
    • Export Citation
  • 33.

    Balasuriya UB, Snijder EJ, van Dinten LC, et al. Equine arteritis virus derived from an infectious cDNA clone is attenuated and genetically stable in infected stallions. Virology 1999; 260:201208.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 34.

    Senne DA, Pearson JE, Carbrey EA. Equine viral arteritis: a standard procedure for the virus neutralization test and comparison of results of a proficiency test performed at five laboratories, in Proceedings. 89th Annu Meet US Anim Health Assoc 1985;29–34.

    • Search Google Scholar
    • Export Citation
  • 35.

    Timoney PJ. World Organization for Animal Health (OIE): OIE manual of diagnostic tests and vaccines for terrestrial animals. 6th ed. Paris: OIE, 2008.

    • Search Google Scholar
    • Export Citation
  • 36.

    Balasuriya UB, Leutenegger CM, Topol JB, et al. Detection of equine arteritis virus by real-time TaqMan reverse transcription-PCR assay. J Virol Methods 2002; 101:2128.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 37.

    Lu Z, Branscum A, Shuck KM, et al. Comparison of two real-time reverse transcription polymerase chain reaction assays for the detection of equine arteritis virus nucleic acid in equine semen and tissue culture fluid. J Vet Diagn Invest 2008; 20:147155.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 38.

    Carter GR. Cultural Procedures Employed for Clinical Specimens. In: Carter GR, Cole JR, eds. Diagnostic procedures in veterinary bacteriology and mycology. 5th ed. San Diego: Academic Press Inc, 1990;1517.

    • Search Google Scholar
    • Export Citation
  • 39.

    Moore BD, Balasuriya UB, Nurton JP, et al. Differentiation of strains of equine arteritis virus of differing virulence to horses by growth in equine endothelial cells. Am J Vet Res 2003; 64:779784.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 40.

    McCollum WH. Studies of passive immunity in foals to equine viral arteritis. Vet Microbiol 1976; 1:4554.

  • 41.

    McCollum WH. Responses of horses vaccinated with avirulent modified-live equine arteritis virus propagated in the E. Derm (NBL-6) cell line to nasal inoculation with virulent virus. Am J Vet Res 1986; 47:19311934.

    • Search Google Scholar
    • Export Citation
  • 42.

    Murphy TV, Slade BA, Broder KR, et al. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants. MMWR Recomm Rep 2008; 57:151.

    • Search Google Scholar
    • Export Citation
  • 43.

    Okuda M, Yamanaka M, Takahashi T, et al. Positive rates for rubella antibody in pregnant women and benefit of post-partum vaccination in a Japanese perinatal center. J Obstet Gynaecol Res 2008; 34:168173.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 44.

    Van Kampen C, Mallard BA. Effects of peripartum stress and health on circulating bovine lymphocyte subsets. Vet Immunol Immunopathol 1997; 59:7991.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 45.

    Kimura K, Goff JP, Kehrli ME Jr, et al. Phenotype analysis of peripheral blood mononuclear cells in periparturient dairy cows. J Dairy Sci 1999; 82:315319.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 46.

    Shafer-Weaver KA, Sordillo LM. Bovine CD8+ suppressor lymphocytes alter immune responsiveness during the postpartum period. Vet Immunol Immunopathol 1997; 56:5364.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 47.

    Dewey CE, Wilson S, Buck P, et al. Effects of porcine reproductive and respiratory syndrome vaccination in breeding-age animals. Prev Vet Med 2004; 62:299307.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 48.

    Dewey CE, Wilson S, Buck P, et al. The reproductive performance of sows after PRRS vaccination depends on stage of gestation. Prev Vet Med 1999; 40:233241.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 49.

    Ellsworth MA, Brown MJ, Fergen BJ, et al. Safety of a modified-live combination vaccine against respiratory and reproductive diseases in pregnant cows. Vet Ther 2003; 4:120127.

    • Search Google Scholar
    • Export Citation
  • 50.

    Raidal SL, McTaggart C, Yovich JV, et al. Effect of withholding macromolecules on the duration of intestinal permeability to colostral IgG in foals, in Proceedings. 46th Annu Am Assoc Equine Pract Conv 2000;260–263.

    • Search Google Scholar
    • Export Citation
  • 51.

    Stott GH, Marx DB, Menefee BE, et al. Colostral immunoglobulin transfer in calves. I. Period of absorption. J Dairy Sci 1979; 62:16321638.

    • Crossref
    • Search Google Scholar
    • Export Citation

Advertisement